Unlock instant, AI-driven research and patent intelligence for your innovation.

Humanized anti-chikungunya virus NSP1 antibody and application thereof

A chikungunya virus and monoclonal antibody technology, applied in antiviral agents, virus/bacteriophage, antiviral immunoglobulin, etc., to achieve high affinity and high specificity effects

Pending Publication Date: 2021-03-26
中国人民解放军东部战区疾病预防控制中心
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, it is possible to control CHIKV infection by inhibiting the expression of viral NSP2 protein and NSP1 protein

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Humanized anti-chikungunya virus NSP1 antibody and application thereof
  • Humanized anti-chikungunya virus NSP1 antibody and application thereof
  • Humanized anti-chikungunya virus NSP1 antibody and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1 Preparation and screening of mouse monoclonal antibody CH001

[0027] 1) Application of hybridoma technology to prepare anti-NSP 1 For monoclonal antibodies, the specific steps are as follows:

[0028] 1. Preparation of antigen (NSP 1 Recombinant protein)

[0029] Construction of NSP1 expression plasmid:

[0030] PCR amplified gene sequence,

[0031] (F(5'-3'): TAGAGCTAGCGAATTCGAATTCCACCATGGAGACCGATACC;

[0032] R (5'-3'): TTGCGGCCGCGGATCCGCGGCCGCTTATCACTTGC), restriction endonucleases EcoRI and NotI digested the target fragment and expression plasmid pET28a respectively, recovered the target fragment and vector fragment by gel, ligated overnight at 16°C according to the ratio, and transformed E. coli DH5α. The positive clones were identified by colony PCR screening, and the plasmids were extracted for double enzyme digestion identification and sequencing.

[0033] Retransform Escherichia coli BL-21(DE3) competent cells with the plasmids that have been d...

Embodiment 2

[0045] Example 2hm NSP 1 Antibody preparation

[0046] After the applicant's previous detection of murine monoclonal antibody, we selected the CH001 hybridoma cell line to prepare the human-mouse chimeric antibody hm CH001.

[0047] 1) Amplification and verification of antibody variable region gene fragments:

[0048] CH001 hybridoma cells were cultured to the logarithmic growth phase, and the total RNA of the cells was extracted by Trizol-chloroform-isopropanol; the dried total RNA of the cells was dissolved in 20 μL of water, and the OD260 / OD280 was measured, and the value was 1.9. Take 14 μL of RNA for reverse transcription, use the mRNA in the total RNA as a template, and use OligodT 15 Single-stranded cDNA was obtained by reverse transcription and amplification.

[0049] Design 19 VH upstream primers and 17 Vκ upstream primers, 4 VH downstream primers and 3 Vκ downstream primers Primers:

[0050] Vκ5' upstream primer:

[0051] Vκ-1

[0052] 5’-GGG CCC AGG CGG CCG AG...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention provides a humanized anti-chikungunya virus NSP1 antibody and application thereof. The light chain variable region of the antibody has a nucleotide sequence shown as SEQ ID NO: 1 and anamino acid sequence shown as SEQ ID NO: 2, wherein the light chain hypervariable region sequences are shown as SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5; the heavy chain variable region has a nucleotide sequence shown as SEQ ID NO: 6 and an amino acid sequence shown as SEQ ID NO: 7, and the heavy chain hypervariable region has sequences shown as SEQ ID NO: 8, SEQ ID NO: 9 and SEQ ID NO: 10. Theantibody can be specifically combined with an NSP1 antigen of the chikungunya virus.

Description

technical field [0001] The invention belongs to the field of chikungunya virus treatment and prevention, and in particular relates to humanized anti-chikungunya virus NSP1 antibody and application thereof. Background technique [0002] Chikungunya virus (CHIKV) is a single-stranded positive-sense RNA virus that can cause Chikungunya fever. Although the fatality rate is not high, the infected people lose their labor force, resulting in serious social impact and economic losses. . CHIKV is a mosquito-borne virus, mainly transmitted to humans by Aedes aegypti and Aedes albopictus. It was first isolated in Tanzania in 1952-1953, and then broke out in Africa and Asia. After 2005, CHIKV broke out several times in many places around the world, and sporadic imported cases appeared in France, Italy, and China. In particular, the E1 protein mutation (E1-A226V) of CHIKV East, Central and South Africa type enables it to effectively pass through white mosquitoes. Aedes transmission pos...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/20C07K16/10C12N15/13C12N15/85C12N5/10G01N33/577G01N33/569A61K39/42A61P31/14
CPCC07K16/1081C12N15/85G01N33/577G01N33/56983A61P31/14C07K2317/52C07K2317/56G01N2333/181C12N2800/107A61K2039/505Y02A50/30
Inventor 周婷婷朱进杨展郑峰
Owner 中国人民解放军东部战区疾病预防控制中心